In the Spotlight
In case you missed it: AACR publications continue to be rated among the most influential journals in cancer research and medicine, based on the 2016 Impact Factors that were recently released in the Clarivate Analytics’ Journal Citation Reports®. All 8 AACR Journals experienced an increase in Impact Factor over last year. Find out more.
Read ‘Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas’ in the August issue of Molecular Cancer Therapeutics (MCT). King and colleagues combine two techniques that allow them to achieve therapeutic radiosensitizer concentrations in the parenchyma and have these levels retained for long time periods to allow a synergistic effect with fractionated radiotherapy. By using convection enhanced delivery, the blood brain barrier is bypassed, and a polymer nanoparticle formulation provides slow release of drug throughout the course of the radiotherapy regimen. These results have shown promising improvements in survival in an aggressive pre-clinical tumor model in rats, and suggest new approaches for treating brain tumors in humans. Read the August issue of MCT.
New! Read, IGH/MYC-positive Cells are Sensitive to PARP1 Inhibitors, by Silvia Maifrede, et al., a just released Molecular Cancer Research Rapid Impact article in the August issue! Find out more about the Rapid Impact article type.
Read about the impactful researchers behind the AACR’s highly cited journal articles! In the Best of the AACR Journals Author Profiles, we learn about why the authors became researchers, what excites them about their fields, and what they do in their spare time. Read their articles in the Best of.
